Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Medical Devices Business Review
Return to: MDBR Home | Companies

Genesis Genomics Inc.

Genesis Genomics Inc.
Suite 310, 1294 Balmoral St.
Thunder Bay
Phone: 1 807 3468100
Fax: 18-07-3468105

Company Overview

Genesis Genomics is a cancer biomarker discovery company that enables early detection and characterization of many types of cancer at molecular level. The company has developed the Biomarker Discovery Platform which is a multi application molecular screening technology that provides clinicians for early screening and also as a better prognostic indicator. It also develops a technology that extends life and decreases treatment costs, assays and services for prostrate and skin cancers. Its technologies also help in improving the quality of life for potential cancer patients. It is headquartered in Ontario, Canada.

Top Competitors

Key Employees

Carole McCollum


Ken Bruley, F.C.A.


Dr. Robert Thayer


Robert J. Poulter

President, Chief Executive Officer, Executive Board

Ryan Parr

Research & Development, Director, Chief Scientific Officer, Executive Board

Gregory Hines

Chairman, Executive Board

Norman Kribs

Director, Non Executive Board

Michael Fowle

Director, Non Executive Board

Harvey Cardwell

Director, Non Executive Board

Harry Smart

Director, Non Executive Board

Mark Birch-Machin

Chief Scientific Officer - UK, Senior Management

Michael Fawcett

Senior Vice President - Business Development, Senior Management

Gabriel Dakubo

Chief Medical Officer, Senior Management


Suite 310, 1294 Balmoral St.,
Thunder Bay,
Phone: 1 807 3468100
Fax: 1 807 3468105

Genesis Genomics UK Ltd.,
Cels At Newcastle, Medical School, University of Newcastle, Framlington Place,
Newcastle Upon Tyne,
United Kingdom
Phone: +44 0191 2211535
Fax: +44 0191 2212050



  • Biomarkers
  • DNA Care Technology